Roughly half of women experience noticeable hair loss at some point, yet most information online is written for men. Following the men’s playbook can be ineffective or outright unsafe for women. The single most important difference: in women, hair loss is far more often a symptom of something findable and fixable, which is why diagnosis comes before treatment.

Step one: figure out which kind of loss it is

Female pattern hair loss, FPHL or androgenetic alopecia

Female pattern hair loss usually shows up as gradual thinning concentrated at the part line and crown, often with a preserved frontal hairline, unlike the classic male receding pattern. The part slowly widens. The ponytail gets thinner. This is the chronic, genetic-hormonal form.

Telogen effluvium, TE

Telogen effluvium is sudden, diffuse shedding all over the scalp, often noticed as handfuls in the shower. It typically starts 2 to 4 months after a trigger: childbirth, major illness including COVID, surgery, crash dieting, severe stress, or starting or stopping certain medications.

The crucial reassurance: TE usually resolves on its own within 6 to 12 months once the trigger passes. It needs a trigger hunt, not a lifetime protocol.

Traction alopecia

Traction alopecia is loss at the hairline and temples from years of tight ponytails, braids, buns, or extensions. Caught early it may be reversible by changing the style. Caught late, the follicles can scar.

Other causes worth ruling out include thyroid disease, iron deficiency, PCOS, autoimmune conditions like alopecia areata’s distinct round patches, and scarring alopecias. Scarring alopecias need urgent dermatology referral because waiting can cost hair permanently.

The lab work worth asking for

Because so many causes are systemic, a basic workup pays for itself:

  • Ferritin, which reflects iron stores. Many dermatologists like to see it well above the normal floor for hair regrowth.
  • TSH, which screens thyroid function.
  • Vitamin D.
  • Androgens, including testosterone and DHEA-S, where PCOS is suspected.

Fixing a ferritin of 12 may do more than any serum ever could.

Treatments with real evidence

Minoxidil: first-line, and the formulation matters

Topical minoxidil is the best-evidenced treatment for FPHL. Options include 2% liquid twice daily, the original women’s approval, or 5% foam once daily, which trials showed works as well as 2% twice daily and is FDA-approved for women. Once-daily 5% foam wins on adherence for most people.

Two honest warnings: the early shedding phase, usually weeks 2 to 8, is normal and temporary. Liquid formulations that drip onto the face or temples can also cause unwanted facial hair. Foam and careful application reduce this risk.

Microneedling

The combination evidence built in men increasingly includes women: adding weekly microneedling to minoxidil improves outcomes in FPHL studies too. The same technique, depth, and safety rules apply. Read the full microneedling and minoxidil guide before starting.

Spironolactone, prescription

For FPHL with an androgen component, or PCOS, dermatologists commonly prescribe spironolactone 100 to 200 mg/day. It is an androgen-receptor blocker with decades of use. Evidence is observational rather than large-RCT, but clinical experience is extensive. It requires a prescription, occasional potassium monitoring, and reliable contraception because it can feminize a male fetus.

The finasteride and dutasteride warning

The men’s DHT-blocker playbook mostly does not transfer. Finasteride and dutasteride are teratogenic, meaning they can cause birth defects in male fetuses. They are generally avoided in women of childbearing age, and results in studies of pre-menopausal women at standard doses have been unimpressive anyway.

Post-menopausal use at higher doses is an emerging, specialist-supervised area. This is firmly with-a-dermatologist territory, not internet-protocol territory. The science of how these drugs work is covered in the finasteride vs. dutasteride guide.

Low-dose oral minoxidil, prescription

One of the biggest shifts in dermatology recently: very low-dose oral minoxidil, usually 0.625 to 2.5 mg, has become a popular off-label option for women who find topicals irritating or impractical, with good tolerability in published cohorts. It is prescription and physician-monitored.

Supportive measures

Where deficiencies exist, correcting iron and vitamin D matters. Supplementing iron without a demonstrated deficiency is not harmless, so test first. Gentle handling helps traction-prone styles: looser styles, satin pillowcases, and avoiding heat on fragile regrowth. Nutrafol and similar supplements have some company-funded trial data. They are expensive, and testing and fixing actual deficiencies comes first.

A realistic women’s protocol

For diagnosed FPHL: 5% minoxidil foam once daily + weekly dermastamp + labs corrected +, with a doctor, spironolactone if androgen-driven. Judge at 6 months with monthly photos of your part line in consistent lighting.

For sudden diffuse shedding: hunt the trigger from the last 2 to 4 months, get the lab panel, and give it time. Most TE resolves. If shedding continues past about 6 months or the part line is clearly widening, see a dermatologist to check for FPHL overlap.

This article is for informational purposes only and is not medical advice. Hair loss in women often signals an underlying condition. Please see a healthcare provider for diagnosis, and never take finasteride, dutasteride, or spironolactone without medical supervision, particularly if pregnancy is possible.